All Stories

  1. Zinc for Infection Prevention in Sickle Cell Anemia (ZIPS): study protocol for a randomized placebo-controlled trial in Ugandan children with sickle cell anemia
  2. Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia
  3. CSF TNF in cerebral malaria and cognitive impairment
  4. Differing Causes of Lactic Acidosis and Deep Breathing in Cerebral Malaria and Severe Malarial Anemia May Explain Differences in Acidosis-Related Mortality
  5. Delaying Iron Therapy until 28 Days after Antimalarial Treatment Is Associated with Greater Iron Incorporation and Equivalent Hematologic Recovery after 56 Days in Children: A Randomized Controlled Trial
  6. Novel Use of Hydroxyurea in an African Region With Malaria: Protocol for a Randomized Controlled Clinical Trial
  7. Timing of iron and antimalarial treatment
  8. Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigens
  9. Micronutrient Deficiency and Immunity
  10. Changes in Antigen-Specific Cytokine and Chemokine Responses to Plasmodium falciparum Antigens in a Highland Area of Kenya after a Prolonged Absence of Malaria Exposure
  11. Sensitivity of fever for diagnosis of clinical malaria in a Kenyan area of unstable, low malaria transmission
  12. Use of a three-band HRP2/pLDH combination rapid diagnostic test increases diagnostic specificity for falciparum malaria in Ugandan children
  13. Cerebral Malaria
  14. Pediatric Infectious Diseases
  15. Infections in Internationally Adopted Children
  16. The Association between Cognition and Academic Performance in Ugandan Children Surviving Malaria with Neurological Involvement
  17. Standardization and validation of a cytometric bead assay to assess antibodies to multiple Plasmodium falciparum recombinant antigens
  18. Immunomodulation inPlasmodium falciparummalaria: experiments in nature and their conflicting implications for potential therapeutic agents
  19. Correction: Recurrent Plasmodium falciparum Malaria Infections in Kenyan Children Diminish T-Cell Immunity to Epstein Barr Virus Lytic but Not Latent Antigens
  20. Faculty Opinions recommendation of Iron deficiency protects against severe Plasmodium falciparum malaria and death in young children.
  21. Faculty Opinions recommendation of Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial.
  22. Faculty Opinions recommendation of Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study.
  23. Recurrent Plasmodium falciparum Malaria Infections in Kenyan Children Diminish T-Cell Immunity to Epstein Barr Virus Lytic but Not Latent Antigens
  24. Faculty Opinions recommendation of Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case-control study and a longitudinal study.
  25. Antibodies to Plasmodium falciparum Erythrocyte-binding Antigen-175 are Associated With Protection From Clinical Malaria
  26. Malaria with neurological involvement in Ugandan children: effect on cognitive ability, academic achievement and behaviour
  27. Diagnosing latent tuberculosis in international adoptees remains challenging
  28. Nitric oxide for the adjunctive treatment of severe malaria: Hypothesis and rationale
  29. Cognition, behaviour and academic skills after cognitive rehabilitation in Ugandan children surviving severe malaria: a randomised trial
  30. Inhaled nitric oxide for the adjunctive therapy of severe malaria: Protocol for a randomized controlled trial
  31. Development of a Competency-Based Curriculum in Global Child Health
  32. Malaria (Plasmodium)
  33. Health Advice for Children Traveling Internationally
  34. Local topographic wetness indices predict household malaria risk better than land-use and land-cover in the western Kenya highlands
  35. Cerebral Malaria: Mechanisms of Brain Injury and Strategies for Improved Neurocognitive Outcome
  36. Adjunctive therapy for cerebral malaria and other severe forms ofPlasmodium falciparummalaria
  37. Primary Autoimmune Neutropenia Uncovered by Methicillin-Resistant Staphylococcus aureus Osteomyelitis
  38. Reply to Landman and Groeneveld
  39. Staphylococcal Toxic Shock Syndrome Erythroderma Is Associated with Superantigenicity and Hypersensitivity
  40. Possible Interruption of Malaria Transmission, Highland Kenya, 2007–2008
  41. Reliability of the Luganda version of the Child Behaviour Checklist in measuring behavioural problems after cerebral malaria
  42. Socioeconomic Predictors of Cognition in Ugandan Children: Implications for Community Interventions
  43. Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals
  44. Environmental, socio‐demographic and behavioural determinants of malaria risk in the western Kenyan highlands: a case–control study
  45. Immediate Neuropsychological and Behavioral Benefits of Computerized Cognitive Rehabilitation in Ugandan Pediatric Cerebral Malaria Survivors
  46. A Note to His Surgeon
  47. Serum Angiopoietin-1 and -2 Levels Discriminate Cerebral Malaria from Uncomplicated Malaria and Predict Clinical Outcome in African Children
  48. Malaria treatment-seeking behaviour and recovery from malaria in a highland area of Kenya
  49. Inpatient Mortality in Children With Clinically Diagnosed Malaria As Compared With Microscopically Confirmed Malaria
  50. Elevated serum levels of IL-1ra in children with Plasmodium falciparum malaria are associated with increased severity of disease
  51. Topography-derived wetness indices are associated with household-level malaria risk in two communities in the western Kenyan highlands
  52. Antibodies to Pre‐erythrocytic Plasmodium falciparum Antigens and Risk of Clinical Malaria in Kenyan Children
  53. Cerebral Malaria Pathogenesis
  54. Low Levels of RANTES Are Associated with Mortality in Children with Cerebral Malaria
  55. Rehabilitation for cognitive impairments after cerebral malaria in African children: strategies and limitations
  56. Therapies and Vaccines for Emerging Bacterial Infections: Learning from Methicillin-resistant Staphylococcus aureus
  57. Antibodies to Plasmodium falciparum Antigens Vary by Age and Antigen in Children in a Malaria-Holoendemic Area of Kenya
  58. Risk of Plasmodium falciparum infection during a malaria epidemic in highland Kenya, 1997
  59. Drug treatment of malaria in children
  60. The revolution in molecular biology leads to new understanding of the clinical expression of immunodeficiencies
  61. Recurrent fever in children
  62. Community-Acquired, Non-Antibiotic-Associated Clostridium difficile Colitis in a Child
  63. About your child
  64. SUCCESSFUL MEROPENEM TREATMENT OF MULTIPLY RESISTANT PNEUMOCOCCAL MENINGITIS
  65. Flogging Trolls